BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng T, Chen SR, Liu HQ, Chong YT, Li XH. Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature. World J Hepatol 2024; 16(6): 966-972 [PMID: 38948434 DOI: 10.4254/wjh.v16.i6.966]
URL: https://www.wjgnet.com/1948-5182/full/v16/i6/966.htm
Number Citing Articles
1
Tao Zeng, Shu-Ying Huang, Jian-Ning Chen, Jia-Hui Pang, Yu-Tian Chong, Xin-Hua Li. Pathogenesis and clinical management of liver damage in porphyrias: Mechanisms and therapeutic approaches. World Journal of Hepatology 2025; 17(9): 107705 doi: 10.4254/wjh.v17.i9.107705
2
Nicole D. Zantek, Caroline R. Alquist, Jan C. Hofmann, Reinhard Klingel, Yosef Levenbrown, Oluwatoyosi A. Onwuemene, Gopal Patidar, Christopher J. Patriquin, Jay S. Raval, Amber P. Sanchez, Jennifer Schneiderman, Yvette C. Tanhehco, Laura Connelly‐Smith. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue. Journal of Clinical Apheresis 2026; 41(S2) doi: 10.1002/jca.70141